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Background: Collaborative practice in healthcare has been recommended to improve the quality of antimicrobial
stewardship interventions, a behavioral change in antimicrobial use. Insufficient knowledge regarding antibiotic
resistance, the fear of complications from infections, and how providers perceive antibiotic use and resistance are
likely to influence prescribing behavior. This study's objective was to identify the knowledge and belief healthcare
professionals' differences about antibiotic stewardship.
Methods: This cross-sectional survey study of three hospitals in the East Java province, Indonesia utilized a 43-
item questionnaire to assess antimicrobial stewardship knowledge and belief. There were 12 knowledge ques-
tions (total possible score: 12) and 31 belief questions (total possible score: 155). The Kuder Richardson 20 (KR-
20) and Cronbach alpha values of the questionnaire were 0.54 and 0.92, respectively.
Results: Out of the 257 respondents, 19% (48/257) had a low scores of knowledge, and 39% (101/257) had low
scores on belief about antibiotic stewardship (101/257). Most midwives had a low scores on knowledge (25/61)
and low scores on belief (46/61). Respondents with high scores on belief were 17% (10/59) physicians, 15% (4/
27) pharmacists, 8% (5/65) nurses, and 3% (2/61) midwives.
Conclusion: Among healthcare professionals, knowledge and belief differences concerning antibiotic stewardship
vary widely. These differences will affect their capability, behavior, and contribution to the healthcare team
collaboration and performance. Further studies are needed to evaluate the correlation between the level of inter-
professional collaboration and the quality of the antibiotic stewardship implementation.1. Introduction
Collaborative practices in healthcare optimize antimicrobial use.
Antimicrobial use in hospitals remains high [1,2]. A study conducted by
the Vermont Oxford Network reported a 34% relative risk reduction of
the median antibiotic use rate with an improved collaborative practice
(leadership, accountability, drug expertise, actions, tracking, reporting,
education) [3]. A decreasing the number of subtherapeutic first troughs
(the risk of development of antimicrobial resistance) and increasing the
number of therapeutic troughs (the increases of treatment effectiveness)wati).
m 25 May 2021; Accepted 18 Jun
evier Ltd. This is an open access a[4] was reported as a result of collaborative practice pharmacist and
physician in determining the initial vancomycin dose for adult patients in
the intensive care unit (ICU). Vancomycin typically takes 36–48 h to
reach a steady state. It was reported that involving a pharmacist, being a
medicine expert, in a physician's rounds in an intensive care unit reduced
prescribing orders by 66% [5].
It is recommended that, to achieve the antimicrobial stewardship
(AMS) goals effectively, an AMS team minimally includes contributions
of either an infectious disease (ID) specialist physician, a microbiologist
(if available) and a pharmacist. An ID physician supervises the overalle 2021
rticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Pharmacists evaluate antibiotic consumption, participate in Drug and
Therapeutics Committee [7] and AMS committee meetings [7,8].
Furthermore, the nurses’ role as a patient caregiver [9], patient advocate
[10], and the one who provides education to patient [11] is essential
[12]. Along with physicians and pharmacists, nurses are the most
consistent patient care givers in reviewing medication charts to admin-
ister medications, monitoring duration and indication for antimicrobial
treatment, monitoring the possibility of drug allergies and side effects
incidence, ensuring timely administration of antimicrobials, and
following up on missed doses [9].
According the World Health Organization (WHO): “Collaborative
practice happens when multiple health workers from different profes-
sional backgrounds work together with patients, families, care givers and
communities to deliver the highest quality of care. It allows health
workers to engage any individual whose skills can help achieve local
health goals.” [13]. There are some theories that support the importance
of collaborative practice in antibiotic stewardship. One is the behavior
change advocated by Michie et. al (2011), which includes the COM-B
model of behavior that identifies three factors for any behavior to
occur: capability (C), opportunity (O), and motivation (M) [14]. The
COM-B model can be applied to understand behavior and to effect
behavioral changes in antibiotic use, whereas the Health Belief Model
(HBM) theory explains and predicts person's behavior. Based on the HBM
theory by Rosenstock, at an individual level, a person's actions are
determined by their beliefs and cues to action [15]. Belief itself consists
of perceived threats (possibility of facing the disease), perceived benefits
(of understanding the benefits of adapting a new behavior), perceived
self-efficacy (one's ability to successfully perform the recommended
behavior), and perceived barriers (cost and obstacles which prevent us
from doing a behavior) [16,17]. Our beliefs are affected by factors as age,
gender, type of profession, length of work, and knowledge. Antibiotics
stewardship programs are used worldwide to control antibiotic resistance
through improving antibiotic use. One of the strategies of the antibiotic
stewardship program is to increase the stakeholder's knowledge about
antibiotic stewardship in using antibiotics judiciously. More than half of
healthcare practitioners in Fitche town, Ethiopia, were found to have
good knowledge (the respondents agree on >70% of the 5-Likert scale
statement of practice) in terminology and effectiveness of antibiotic
stewardship [18]. However, very few health practitioners (16%) adhered
consistently to the management of the antibiotic stewardship program
[18]. Moreover, a study at a Riyadh hospital in Saudi Arabia reported
that among 212 physicians; 119 (56%) physicians believed that anti-
biotic resistance causes problems in the community and economic losses
for the country; 101 (48%) physicians believed injudicious empiric an-
tibiotics therapy was the main factor in the occurrence of antibiotic
resistance; and 95 (45%) physicians were unsure about their knowledge
about the appropriate use of antibiotics [19]. A qualitative study in
Indonesia explored the education and awareness of healthcare pro-
fessionals. The participants said that in the university, the lecturer should
teach students more about the impact of antibiotic resistance; and the
professional organization should provide education for practicing
healthcare to keep them up to date with the latest developments [20].
Besides knowledge, the predictor of an effective team performance was
trust level, years of previous experience, and the number of team mem-
bers [21]. The objective of this study was to identify the knowledge’ and
belief' (perceived threat, perceived self-efficacy, perceived benefit, and
perceived barrier) of healthcare professionals regarding antibiotic
stewardship to be able to design training to meet their needs.
2. Methods
This research was an observational descriptive study with a cross-
sectional design. The research material was drawn from a question-
naire completed by healthcare professionals in a private hospital in
Surabaya and two public hospitals in Mojokerto and Pasuruan. The2
questionnaire was developed and validated with the different re-
spondents at the respective hospital before collecting the data. The Kuder
Richardson 20 (KR-20) for the knowledge and Cronbach's alpha values
for the belief, of the questionnaire were 0.54 and 0.92, respectively.
Participants are healthcare practitioners who are associated with anti-
biotic prescribing and use. The professions included in this study are
doctors, pharmacists, midwives, the AMS team members, nurses. The
excluded professions are psychiatrists, radiologists, obstetric and
neonatal nurses, and hemodialysis nurses. The minimum sample size (n)
required is 24 respondent; based on the formula below, where n is the
minimum sample size, the Z value for p <0.05 is 1.96, the unknown
population size (P) is 0.5, and to obtain 0.2 effect difference (d) [22].
The research questionnaire was delivered face-to-face or collected by
the chief nursing officer in the hospital. The respondents provided a
written consent, after they understood the research objective and agree
to participate; and answered the research questionnaire. The question-
naire consisted of 43 questions (Appendix 1). Of these, 12 questions were
used to assess knowledge, and 31 questions to assess belief. The 31 belief
questions consisted of 10 questions to assess perceived threats, 11
questions to assess perceived self-efficacy, 8 questions to assess perceived
benefits, and 2 questions to assess perceived barriers. The responses to
the knowledge questions were measured using the Guttman scale, which
specifies a Yes or No answer. The maximum score of the knowledge
questionnaire was 12, whereas the belief questionnaire was measured
using a 5-point Likert scale. The belief score was a composite score (31
item questions; maximum score 155) which included the perceived
threat score (10 item questions; maximum score 50), perceived self-
efficacy score (11 item questions; maximum score 55), perceived
benefit score (8 item questions; maximum score 40), and perceived
barrier score (2 item questions; maximum score 10). There were three
categories: high, moderate, and low. The number of respondents in the
high category was the number of respondents who had scores higher than
the mean value  one standard deviation (SD). The number of the re-
spondents in the moderate knowledge or belief category was the number
of respondents who had scored in the range of mean value one SD. Any
respondent with a score lower than the moderate category's score (mean
value one SD) was counted in the low category. We performed a simple
random data collection (probability sampling) for nurses' groups (65
nurses from 406 nurses) and complete data collection (nonprobability-
sampling) for other groups of professions to get a proportionate number
among groups. This study is a descriptive analysis to statistically describe
the knowledge and belief score. The healthcare professional's knowledge
and belief differences were analyzedwith the Kruskal–Wallis test because
the data are not normally distributed.
2.1. Ethical considerations
All procedures performed involving human participants were done in
accordance with the ethical standards of the institutional and/or national
research committee and with the 1964 Helsinki Declaration and its later
amendments or comparable ethical standards. Written consent to
participate was obtained from each study participant. The study was
approved by the respective hospital managements (Surabaya city: No.
1299/RSHU/Dir./X/2017; Mojokerto district: No. 423.4/4882/
416–207/2017; and Pasuruan district: No: 455.1/2752/424.202/2017)
and was conducted in accordance with the Indonesian Law for the Pro-
tection of Personal Data. The study was ethically cleared by the Health
Research Ethics Committee of Politeknik Kesehatan Kemenkes Surabaya,
Kementerian Kesehatan No.025/S/KEPK/V/2017.
3. Results
The study population consisted of representatives from five pro-
fessions: nurses, midwives, pharmacists, pharmacy technicians, and
physicians. Table 1 shows the baseline characteristics of the respondents.
At a private hospital in Surabaya city, the response rate was 83% (245/
Table 1. Baseline characteristics of healthcare practitioners.
Variable Professions (N ¼ 257)
Nurses (n ¼ 65) Midwives (n ¼ 61) Pharmacists (n ¼ 27) Pharmacy technicians (n ¼ 45) Physicians (n ¼ 59)
n % n % n % n % n %
Gender Female 48 74 61 100 25 93 43 96 30 51
Male 17 26 - - 2 7 2 4 29 49
Work experience 3 years 10 15 7 11 16 59 7 16 15 25
>3 years 55 85 54 89 11 41 38 84 44 75
F. Herawati et al. Heliyon 7 (2021) e07377296), and 179 met the inclusion and exclusion criteria; at a public hos-
pital in Mojokerto district, the response rate was 77% (153/200), and
153 met the inclusion and exclusion criteria; and at a public hospital in
Pasuruan district, the response rate was 87% (307/352), and 257met the
inclusion and exclusion criteria. There were 65 nurses, 61 midwives, 27
pharmacists, 45 pharmacy technicians, and 59 physicians included in the
analysis.
Nineteen percent (48/257) of the respondents had low scores (below
mean value  one SD) knowledge about antimicrobial stewardship
(Table 2). The mean of antibiotic stewardship knowledge of total re-
spondents was 9.9 (1.5) (Table 3, Figure 1). The mean of antibiotic
stewardship knowledge of the pharmacist and physicians was higher
than that of the pharmacy technicians, nurses, and midwives.
The physicians had a high score of perceived threat, perceived self-
efficacy, perceived benefit, and an average score of perceived barrier
compared with other professions. The pharmacists had a high score for
perceived threat and perceived barrier and a low score for perceived self-
efficacy and perceived benefit compared with other professions
(Table 4). The total score knowledge and belief healthcare professionals
differences were statistically significant (p <0.05).
Work experience affected the knowledge (p ¼ 0.07) and belief (p ¼
0.001) of the pharmacists significantly, but the Kruskal–Wallis test
showed that the association between work experience and knowledge or
belief of other professions (nurses, midwives, pharmacy technicians, and
physicians) was not significant.
4. Discussion
Knowledge about antibiotic stewardship varies among different
groups of healthcare practitioners. The lack of knowledge may cause
inappropriate use of antibiotics. However, antibiotic stewardship
knowledge can be increased with education and training. A study in DireTable 2. The respondent knowledge classification.
Classification Professions (N ¼ 257)
Nurses (n ¼ 65) Midwives (n ¼ 61) Pharmacists (n ¼ 27)
n % n % n %
High 0 0 0 0 0 0
Moderate 54 83 36 59 26 96
Low 11 17 25 41 1 4
Table 3. The descriptive statistics (N ¼ 257).
Variable Mean Standard deviation Min
Knowledge 9.85 1.532 3
Belief 118.41 8.933 97
Threat 37.77 5.418 25
Self-efficacy 41.86 3.891 28
Benefit 31.68 2.880 14
Barrier 7.10 1.217 4
3
Dawa, Ethiopia with a total of 218 paramedical staffs (41 health officers,
96 nurses, 31 pharmacists, 21 midwives, and 29 medical laboratory
technologists) showed that the level of knowledge about the causes of
antimicrobial resistance for the pharmacists (77.4%), health officers
(75.6%), and nurses (63.5%) was higher than that of lab technologists
(44.8%) and midwives (38.1%). That study also showed that 90.4%
(197/218) had not attended any training on antimicrobial resistance;
that 96.8% (211/218) of the participants of the study had not used
antimicrobial sensitivity test results for treating the patients, and that
only 15.7% of them reported referring to the guidelines whenever caring
for a patient [23]. Along with education and training, capabilities of
healthcare practitioners will also increase. A study on long-term educa-
tional effects of antibiotic prescribing in 171 doctors showed that anti-
biotic prescribing in the intervention group was reported as having a
more significant decrease compared with that in the control group. There
were two intervention subgroups. First, a 2-day seminar about
evidence-based medicine for respiratory infections (evidence-based
medicine subgroup). Second, an additional 1-day seminar focused on
problem-solving strategies (evidence-based medicine plus
problem-solving strategies subgroup) [24] The studies indicated that the
education about the benefits of limiting antibiotic use is urgently needed
for healthcare professionals [25,26]. These findings will be used by
hospital management to design better educational material for the next
antibiotic stewardship training for healthcare professional that associ-
ated with antibiotic use.
There are differences in knowledge and belief among healthcare
professionals. There is a positive correlation between knowledge and
behavior. The knowledge about antibiotic stewardship will affect anti-
biotic use behavior. Furthermore, there is a positive correlation between
self-efficacy and perceived benefit, and a negative correlation between
self-efficacy and perceived barrier [16]. Nair et al. reported that there
was a statistically significant difference in average scores of knowledge,Pharmacy technicians (n ¼ 45) Physicians (n ¼ 59) Total (N ¼ 257)
n % n % n %
0 0 0 0 0 0
42 93 51 86 209 81
3 7 8 14 48 19







Figure 1. Mean scores of variables.
F. Herawati et al. Heliyon 7 (2021) e07377attitude, and practice questions among allopathic doctors, nurses, phar-
macy shopkeepers, and informal health providers in Paschim Bardhaman
District, India [27]. A study of 135 nurses from two hospitals in Mashhad,
Iran showed that education intervention in the intervention group
increased the participants’ knowledge, and that there was a significant
relationship between knowledge and perceived threat or perceived
benefit [17]. A study of the HBM as an explanatory framework in
communication research recommended further research to evaluate theTable 4. The respondent belief classification.
Category Professions (N ¼ 257)
Nurses (n ¼ 65) Midwives (n ¼ 61) Pharmacists (n ¼ 27)
n % n % n %
Belief
Strong 5 8 2 3 4 15
Moderate 54 83 13 21 9 33
Weak 6 9 46 75 14 52
Perceived Threat
High 4 6 0 0 5 19
Moderate 55 85 41 67 22 81
Low 6 9 20 33 0 0
Perceived Self-efficacy
High 14 22 7 11 3 11
Moderate 50 77 54 89 20 74
Low 1 2 0 0 4 15
Perceived Benefit
High 9 14 4 7 0 0
Moderate 52 80 54 89 19 70
Low 4 6 3 5 8 30
Perceived Barrier
High 7 11 9 15 7 26
Moderate 55 85 48 79 20 74
Low 3 5 4 7 0 0
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causal effect of the behavior variable and which variable was a strong
predictor of behavior change [15].
Education is effective in reducing antibiotic prescribing, but edu-
cation combined with direct intervention in supporting the imple-
mentation of rational antibiotic use is more effective than education
alone [28,29]. Some interventions identified were public awareness
campaigns [26], antimicrobial guidelines [30], professional regulation
[31], restricted reimbursement [32], pay for performance, and pre-
scription requirements [32,33]. Collaborative practice and recommen-Total
Pharmacy technicians (n ¼ 45) Physicians (n ¼ 59)
n % n % n %
1 2 10 17 22 9
13 29 45 76 134 52
31 69 4 7 101 39
0 0 18 31 27 11
41 91 40 68 199 77
4 9 1 2 31 12
1 2 8 14 33 13
44 98 51 86 219 85
0 0 0 0 5 2
0 0 7 12 20 8
39 87 50 85 214 83
6 13 2 3 23 9
0 0 8 14 31 12
45 100 48 81 216 84
0 0 3 5 10 4
F. Herawati et al. Heliyon 7 (2021) e07377dation acceptance by the clinical provider is also important for an
antibiotic stewardship program [34] and for collaborative approaches
to appropriate antimicrobial use [35]. Logan's study in 28 hospitals
showed that collaborative practice in antibiotic stewardship increased
days of therapy (DOT) per 1,000 patient-days of broad-spectrum anti-
biotics reduction from 1%–2.5% to 5%–10% [36].
In this study, the association of work experience and the knowledge
or belief were inconsistent. Among the pharmacists' subgroup, the work
experience was associated with different score knowledge or belief, but
among other professions (nurses, midwives, pharmacy technicians, and
physicians) subgroup, the work experience was not associated with the
knowledge or belief score. These results are comparable to the findings
reported by by Tegagn et al. from a study in Fitche Hospital, Ethiopia,
were profession and years of experience were not significant predictors of
healthcare professionals’ knowledge, attitude, and practices towards
antimicrobial stewardship [18].
Our study has a number of limitations. First, it is not fully represen-
tative for the sample population because not all healthcare practitioners
filled in the questionnaire. This is the nonresponse error, reflecting the
results of the individuals who did not respond to the survey. Second,
there is measurement error, occurring when survey responses are not
accurate reflections of the true value because of social desirability bias
[37].
5. Conclusion
Among healthcare professionals, knowledge and belief differences of
antibiotic stewardship vary widely. Antibiotic knowledge is associated
with positive belief and behavior that contribute to adherence to a
judicious use of antibiotics and reduce antibiotic utilization. Knowledge
about antibiotics and resistance relates to the understanding of the
antibiotic misuse concept and awareness of antimicrobial resistance. The
Health Belief Model (HBM) theory presume several constructs (perceived
severity, perceived benefit, self-efficacy, cues of action) to predict
behavior. Perception about the severity and consequences of the disease
and the benefits of antibiotic treatment for infectious disease are de-
terminants of antibiotic use and prescribing behavior [15]. Further
studies are needed to evaluate the correlation between the level of
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Work place (unit/division):True False
n bakteri resisten terhadap antibiotik.
ecome resistant to antibiotics.
m obat tersebut dapat menyebabkan bakteri
resistant to antibiotics.
kan bakteri resisten terhadap antibiotik.
on, causes bacteria to become resistant to
perawat saja.
by nurses only.
babkan bakteri resisten terhadap antibiotik.
cause bacteria to become resistant to
gkatkan efek samping obat.
dose can increase the side effects of the
(continued on next page)
(continued )
Number Statement True False
7. Pemberian informasi penggunaan antibiotik kepada pasien dapat mencegah bakteri resisten terhadap antibiotik.
Providing information on the use of antibiotics to patients can prevent bacteria becoming resistant to
antibiotics.
8. Peta kuman di rumah sakit dapat membantu mengetahui bakteri yang resisten terhadap antibiotik.
Antibiotic sensitivity patterns in the hospital can help to identify antibiotic-resistant bacteria.
9. Lama pemberian antibiotik yang tidak sesuai dengan jenis infeksi, menyebabkan bakteri resisten terhadap
antibiotik.
The duration of antibiotic administration not following the type of infection, may cause bacteria to become
resistant to antibiotics.
10. Cara pemberian antibiotik yang tidak sesuai dengan aturan dapat menyebabkan bakteri resisten terhadap
antibiotik.
Give antibiotics without following the rules can cause bacteria to become resistant to antibiotics.
11. Pelaksanaan Program Pengendalian Resistensi Antibiotik (PPRA) cukup dilakukan oleh dokter saja.
The implementation of the Antibiotic Resistance Control Program (PPRA) can only be done by a doctor.
12. Mencuci tangan sebelum dan sesudah kontak fisik/penyiapan sediaan injeksi kepada pasien dapat mengurangi
transmisi/penularan penyakit infeksi.
Washing hands before and after physical contact/preparing injections to patients can reduce the
transmission of infectious diseases.
Number Statement Strongly Disagree Disagree Neutral Agree Strongly Agree
1. Pemberian antibiotik pada bakteri yang resisten terhadap antibiotik tersebut dapat
memperpanjang lama rawat inap.
Giving antibiotics to bacteria that are resistant to antibiotics can prolong the
length of hospitalization.
2. Bakteri resisten terhadap antibiotik dapat meningkatkan biaya pengobatan pada
pasien yang terinfeksi.
Antibiotic-resistant bacteria can increase treatment costs in infected patients.
3. Bakteri resisten terhadap antibiotik meningkatkan frekuensi pemeriksaan
laboratorium pada pasien yang terinfeksi.
Antibiotic-resistant bacteria increase the frequency of laboratory tests in
infected patients.
4. Bakteri resisten terhadap antibiotik dapat menyebabkan terjadinya sepsis.
Bacterial resistance to antibiotics can cause sepsis.
5. Bakteri resisten terhadap antibiotik dapatmenyebabkan risiko pasien dirawat di
intensive care unit (ICU) atau ruang isolasi.
Bacterial resistance to antibiotics can put the patient at risk of being admitted
to the intensive care unit (ICU) or isolation room.
6. Bakteri resisten terhadap antibiotik dapat meningkatkan resiko mortalitas pada
pasien yang terinfeksi.
Antibiotic-resistant bacteria can increase the risk of mortality in infected
patients.
7. Profesi saya beresiko terinfeksi bakteri yang resisten terhadap antibiotik.
My profession is at risk of infection with antibiotic-resistant bacteria.
8. Penggunaan kombinasi antibiotik karena bakteri resisten dapat meningkatkan efek
samping obat.
The use of a combination of antibiotics due to resistant bacteria can increase
the side effects of the drug.
9. Bakteri resisten terhadap antibiotik dapat menyebabkan risiko penggunaan
ventilator pada pasien yang terinfeksi.
Antibiotic-resistant bacteria may pose a risk of ventilator use in infected
patients.
10. Bakteri resisten terhadap antibiotik membebani keuangan negara dalam
pembiayaan jaminan kesehatan nasional.
Antibiotic-resistant bacteria burden the state's finances in financing national
health insurance.
11. Laboratorium mikrobiologi di rumah sakit saya dapat mendukung keberhasilan
Program Pengendalian Resistensi Antibiotik (PPRA).
The microbiology laboratory at my hospital can support the success of the
Antibiotic Resistance Control Program (PPRA).
12. Penjelasan saya tentang penggunaan antibiotik dapat dipahami pasien.
My explanation about the use of antibiotics is understandable for the patient.
13. Saya berkoordinasi dengan tenaga kesehatan lain ketika pasien mendapatkan
antibiotik bersamaan dengan obat lain.
I attune with other healthcare practitioners when patients receive antibiotics
along with other drugs.
14. Pencampuran (rekonstitusi) sediaan antibiotik dilakukan dengan baik di rumah
sakit saya.
Mixing (reconstitution) of antibiotic preparations is done well in my hospital.
(continued on next page)
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(continued )
Number Statement Strongly Disagree Disagree Neutral Agree Strongly Agree
15. Saya mengkonfirmasi peresepan/cara penggunaan antibiotik sebelum diberikan ke
pasien dengan tenaga kesehatan lain.
I confirm the prescribing/how to use antibiotics before giving them to patients
with other healthcare practitioners.
16. Farmasis di rumah sakit saya menjamin stabilitas hasil pencampuran sediaan
antibiotik.
The pharmacists in my hospital guarantee the stability of the reconstituted
antibiotic preparations.
17. Saya mengganti antibiotik bila hasil laboratorium menunjukkan bakteri resisten
terhadap antibiotik meskipun kondisi klinik membaik.
I change antibiotics when the laboratory results show that bacteria are
resistant to antibiotics even though the clinical condition is improving.
18. Pedoman Penggunaan Antibiotik (PPAB) di rumah sakit saya telah digunakan
sebagai pedoman dalam penggunaan antibiotik.
The Antibiotic Use Guideline (PPAB) in my hospital have been used as
guidelines in the use of antibiotics.
19. Formularium rumah sakit saya telah memberi batasan (restriksi) yang jelas tentang
penggunaan antibiotik.
My hospital formulary has clearly defined the use of antibiotics.
20. Farmasis di rumah sakit saya merekomendasikan perubahan antibiotik parenteral
ke oral jika kondisi pasien membaik.
The pharmacists in my hospital recommends changing parenteral to oral
antibiotics if the patient's condition improves.
21. Saya melanjutkan antibiotik bila kondisi klinik pasien membaik setelah 48–72
jam.
I continue antibiotics if the patient's clinical condition improves after 48–72 h.
22. Penggunaan antibiotik di rumah sakit saya rasional (sesuai indikasi, tepat dosis,
frekuensi, rute pemberian dan lama terapi).
The use of antibiotics in my hospital is rational (according to indication,
dosage, frequency, route of administration, and duration of therapy).
23. Penggunaan antibiotik pada pasien dapat dipantau/dievaluasi dengan baik.
The use of antibiotics in patients can be monitored/evaluated properly.
24. Tenaga kesehatan di rumah sakit saya dapat memilih dan merekomendasikan
antibiotik dengan baik.
The healthcare practitioners in my hospital are well able to choose and
recommend antibiotics.
25. Pedoman Penggunaan Antibiotik (PPAB) di rumah sakit saya diperbarui secara
berkala.
The Antibiotic Use Guideline (PPAB) in my hospital are updated regularly.
26. Pemeriksaan laboratorium untuk pasien yang terinfeksi diperiksa sesuai kebutuhan.
Laboratory tests for infected patients are checked as needed.
27. Koordinasi antar tenaga kesehatan (dokter, perawat, apoteker) yang baik
mendukung keberhasilan terapi.
Good coordination between healthcare practitioners (doctors, nurses,
pharmacists) supports the success of therapy.
28. Pembatasan penggunaan antibiotik oleh formularium rumah sakit menurunkan
kejadian bakteri resisten terhadap antibiotik.
Restrictions on the use of antibiotics by hospital formularies reduce the
incidence of antibiotic-resistant bacteria.
29. Penggantian antibiotik dari spektrum luas ke spektrum lebih sempit sesuai penyebab
infeksi menurunkan kejadian bakteri resisten terhadap antibiotik.
Switching from broad-spectrum to narrower-spectrum antibiotics according to
the cause of infection reduces the incidence of antibiotic-resistant bacteria.
30. Pengetahuan tentang bakteri yang resisten dapat membantu keberhasilan terapi.
Knowledge of resistant bacteria can help in successful therapy.
31. Waktu pemeriksaan yang lama di laboratorium mikrobiologi tidak berpengaruh
pada keberhasilan terapi pada pasien yang terinfeksi.
Long examination time in microbiology laboratory has no effect on the success
of therapy in infected patients.
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I read in your website that this journal is not free of charge for publication. let me know that is it
Melanie Ortiz 2 years ago
Dear user, we suggest you to consult the journal's website or Scopus database directly.
For other indicators like ISI or Impact Factor, we suggest you to consult the Journal




Melanie Ortiz 2 years ago
Dear user, SCImago Journal and Country Rank uses Scopus data, our impact indicator is
the SJR. Check our web to locate the journal. We suggest you to consult the Journal
Citation Report for other indicators (like Impact Factor) with a Web of Science data
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Dear Deni, 
thank you very much for your comment, unfortunately we cannot help you with your
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Dear Colleagues
I am interested to submit a paper (or more) to your journal... I would like to ask about the average
Elena Corera 3 years ago
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Dear Sir or Madham 
Could you please give me the impact factor for this journal ?
best regards
reply
Maria Helena Andrade Santana 3 years ago
Dear Sir or Madham 
Could you please give me the impact factor for this journal ?
best regards
Elena Corera 3 years ago
Dear Achmad, we suggest you locate the author's instructions on the journal's website.
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Dear Maria Helena, SCImago Journal and Country Rank uses Scopus data, our
impact indicator is the SJR. Check our page to locate the journal. We suggest you
consult the Journal Citation Report for other indicators (like Impact Factor) with a
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Does this journal has or will have an impact factor?
Thank you in advance
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Dear Hashim, the SJR data of the journal are on this page, see the evolution graphs of the
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Dear Mikle, SJR uses Scopus data, our impact indicator is the SJR. Check our page to
locate the journal. We suggest you consult the Journal Citation Report for other indicators
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Antibiotic stewardship knowledge and belief differences among healthcare professionals in hospitals: A 
survey study 
Fauna Herawati, Abdul Kadir Jaelani, Heru Wijono, Abdul Rahem, •.. Diantha Soemantri 
Article e07377 




Collaborative practice in healtihcare has been recommended to improve the quality of antimic:robial stewardship intel'\,.entions, a 
behav-ioral change in antimicrobial use. Insufficient knowledge regarding antibiotic resistance. the fear of complications from 
infections, and how p~'iders percei~ antibiotic use and resistance are likely to influence prescribing behariot. This study's 
objecti~ was to identifY the knowledge and beliefhealthcare professionals' differences about antibiotic stewardship. 
Methods 
This eross-sectional sun-ey study of three hospitals in the East Java province. Indonesia utilized a 43-item questionnaire to assess 
0 l«.$$.3.rch a rtk:l$ • Open ~::c.es$ 
v 
Effect of tillage, biochar, poultry manure and NPK 15-15-15 fertilizer, and their mixture on soil prop~ties, 
growth and carrot (Dauc:us carota L.) yield under tropical conditions 
Taiwo Michaei Agbede 
Article e07391 
.±. Download PDF Article preview A 
Abstract 
Ab stract 
Tillage, biochat, poultry manure. NPK fertilizer and their combined application could improve soil quality, sustainability and 
carrot producti~ty. The effects ofh\'0 tillage treatments: oon.,·entional tillage (cr}and reduced tillage (RT} each combined~~ 30 
Mgba-1 biocbar (B110Mgba-1 poul!rymanure(PM1 300kgha-1 NPK 15·15-15 tl!rtilizer, 150kgba-1 NPKlS-15·15 feztilizer +15 
Mg ha-1 biochar +5 Mg ha-1 poultry manure and a control (no biocharjpoultry manurejNPK fertilizer} on soil properties, gro~1h 
and carrot yield ':'.'ere in~gated. The research was carried out for two consecu~·e growing seasons{201S and 2019) at Owo in 
the forest-saruma trmsition •one ofN'~geria on a sandy loam.. The elj)eriment was laid out in a randonmed oomplete block 
design in a :factorial combination often treatments and replicated thre:e times. Reduced tillage had relati"·ely lo~u soil bulk 
density, penetration resistance,. dispersion ratio and temperature. and had significantly bigher{p = 0.05) soil aggregate stability. 
